Catalent Takes Juniper Pharmaceuticals Private
Catalent, Inc. (NASDAQ: CTLT), a contract research organization (CRO), announced its acquisition of thinly traded nano cap Juniper Pharmaceuticals (NASDAQ: JPR) for $139.6 million. Catalent, based in Somerset, New Jersey, offers development services, delivery technologies and supply solutions for drugs and biologics. On a trailing 12-month basis, the company generated revenue of $2.4 billion, and EBITDA of $484.6 million. Juniper, based in Boston, Massachusetts, focuses on developing novel intra-vaginal therapeutics that address unmet medical needs in women’s health. This deal includes Juniper’s UK-based Juniper Pharma Services division, a high-end CRO. The transaction... Read More »
Amazon Scoops Up PillPack for $1 Billion
Amazon (NASDAQ: AMZN) finally took the plunge into the pharmaceutical market with its approximately $1 billion acquisition of five-year-old PillPack, an online pharmacy startup based in Manchester, New Hampshire. Financial terms weren’t disclosed in the deal’s announcement, but on June 28, the day of the announcement, The Wall Street Journal quoted sources on the price. In April 2018, Walmart (NYSE: WMT) was reported to be in discussions with PillPack, and targeting a price under $1 billion, according to CNBC. Amazon was also said to be holding discussions with the company at the time. PillPack is an online pharmacy that delivers medications in pre-sorted dose packaging and... Read More »
Sperm and Egg Bank Merges with Stem Cell Company
June is thought to be the most popular month for weddings, and new beginnings. That wasn’t what sparked the merger of California Cryobank and Cord Blood Registry (CBR) on June 15, but it certainly put marriage and families front and center. California Cryobank, a portfolio company of Longitude Capital and NovaQuest Capital, is the world’s leading donor sperm and donor egg bank. The private equity firms acquired the company in August 2014 for an undisclosed amount, and less than four years later have sold it to GI Partners in San Francisco. That price was also not disclosed. In a separate transaction, GI Partners acquired CBR, the world’s largest stem cell collection and... Read More »
Walgreens Buys Pharmacies from Detroit Medical Center
The Detroit Medical Center (DMC) sold off its retail and outpatient pharmacy business to Walgreens, a unit of Walgreens Boots Alliance (NYSE: WBA), for an undisclosed amount, according to Crain’s Detroit Business. The deal includes seven specialty pharmacy sites and one mail-order service business. The DMC made the move as part of a pharmacy reorganization, a process that has resulted in layoffs or reassignments of some two dozen employees. The hospital is part of Tenet Healthcare Corp. (NYSE: THC), which has been in the process of selling non-core hospitals and reorganizing to pare down debt. Walgreens will operate branded specialty pharmacy outlets at some of DMC’s six... Read More »
Healthcare Services Roundup through April 2018
It’s been quite a year for healthcare deals in general, with nearly 600 announced transactions in the first four months. That’s 7% more than there were announced in the first four months of 2017. Dollar volume has soared, too. In 2018, $141.8 billion has already been committed to fund the 588 transactions. Thanks to some mega-billion-dollar deals in 2018, the total is 30% greater than the nearly $109 billion spent in the same period of 2017. Collectively, the Services sectors are booming, which isn’t always the case. Services deals made up 63% of all deals in the first four months of 2018, and 57% of the disclosed dollars, now at $81.3 billion. The Technology sectors... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
